Login Register Cart 0
Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Letter to the Editor

Response to Letter to the Editor by Briana and Malamitsi-Puchner: Effects of Pregnancy-induced Insulin Resistance on the Fetus and the Future Development of Metabolic Diseases in Adulthood

Author(s): Alfonso Mate*, Antonio J. Blanca, Rocío Salsoso, Fernando Toledo, Pablo Stiefel, Luis Sobrevia* and Carmen M. Vázquez*

Volume 18, Issue 4, 2020

Page: [423 - 424] Pages: 2

DOI: 10.2174/157016111804200507091851

« Previous
[1]
Mate A, Blanca AJ, Salsoso R, et al. Insulin therapy in pregnancy hypertensive diseases and its effect on the offspring and mother later in life. Curr Vasc Pharmacol 2019; 17(5): 455-64.
[http://dx.doi.org/10.2174/1570161117666181114125109] [PMID: 30426902]
[2]
Briana DD, Malamitsi-Puchner A. Effects of pregnancy-induced insulin resistance on the fetus and the future development of metabolic diseases in adulthood. Curr Vasc Pharmacol 2020; 18: 421-2.
[http://dx.doi.org/10.2174/1570161117999190823154608] [PMID: 31441727]
[3]
Maric-Bilkan C, Abrahams VM, Arteaga SS, et al. Research recommendations from the national institutes of health workshop on predicting, preventing, and treating preeclampsia. Hypertension 2019; 73(4): 757-66.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.11644] [PMID: 30686084]
[4]
Davis EF, Lazdam M, Lewandowski AJ, et al. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics 2012; 129(6): e1552-61.
[http://dx.doi.org/10.1542/peds.2011-3093] [PMID: 22614768]
[5]
Stuart JJ, Tanz LJ, Cook NR, et al. Hypertensive disorders of pregnancy and 10-year cardiovascular risk prediction. J Am Coll Cardiol 2018; 72(11): 1252-63.
[http://dx.doi.org/10.1016/j.jacc.2018.05.077] [PMID: 30190003]
[6]
Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension 2010; 56(1): 166-71.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.110.150078] [PMID: 20516394]
[7]
Newbern D, Freemark M. Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes 2011; 18(6): 409-16.
[http://dx.doi.org/10.1097/MED.0b013e32834c800d] [PMID: 21986512]
[8]
Bittencourt MS, Hajjar LA. Insulin therapy in insulin resistance: could it be part of a lethal pathway? Atherosclerosis 2015; 240(2): 400-1.
[http://dx.doi.org/10.1016/j.atherosclerosis.2015.04.013] [PMID: 25890058]
[9]
Salsoso R, Guzmán-Gutiérrez E, Sáez T, et al. Insulin restores L-arginine transport requiring adenosine receptors activation in umbilical vein endothelium from late-onset preeclampsia. Placenta 2015; 36(3): 287-96.
[http://dx.doi.org/10.1016/j.placenta.2014.12.007] [PMID: 25573092]
[10]
Westermeier F, Salomón C, González M, et al. Insulin restores gestational diabetes mellitus-reduced adenosine transport involving differential expression of insulin receptor isoforms in human umbilical vein endothelium. Diabetes 2011; 60(6): 1677-87.
[http://dx.doi.org/10.2337/db11-0155] [PMID: 21515851]
[11]
Howell KR, Powell TL. Effects of maternal obesity on placental function and fetal development. Reproduction 2017; 153(3): 97-108.
[http://dx.doi.org/10.1530/REP-16-0495] [PMID: 27864335]
[12]
Bao LX, Shi WT, Han YX. Metformin versus insulin for gestational diabetes: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2019; 1-13.
[http://dx.doi.org/10.1080/14767058.2019.1670804] [PMID: 31558075]
[13]
Tarry-Adkins JL, Aiken CE, Ozanne SE. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: A systematic review and meta-analysis. PLoS Med 2019; 16(8) e1002848
[http://dx.doi.org/10.1371/journal.pmed.1002848] [PMID: 31386659]
[14]
Subiabre M, Silva L, Toledo F, et al. Insulin therapy and its consequences for the mother, foetus, and newborn in gestational diabetes mellitus. Biochim Biophys Acta Mol Basis Dis 2018; 1864(9 Pt B): 2949-56.
[http://dx.doi.org/10.1016/j.bbadis.2018.06.005] [PMID: 29890222]
[15]
Subiabre M, Villalobos-Labra R, Silva L, et al. Insulin therapy and foetoplacental endothelial dysfunction in gestational diabetes mellitus. In: Frontiers in Clinical Drug Research-Diabetes and Obesity (FCDR-DO). Atta-ur-Rahman, ed. Bentham Science Publishers, Sharjah, United Arab Emirates. Vol. 5, Chapter 1. 1-20. (In Press).
[16]
Silva L, Subiabre M, Araos J, et al. Insulin/adenosine axis linked signalling. Mol Aspects Med 2017; 55: 45-61.
[http://dx.doi.org/10.1016/j.mam.2016.11.002] [PMID: 27871900]

Rights & Permissions Print Cite
Article Metrics
5
© 2024 Bentham Science Publishers | Privacy Policy